Feedback / Questions
AB-101a - Alphyn Biologics
https://www.prnewswire.com/news-releases/alphyn-biologics-reports-positive-results-from-first-cohort-of-phase-2a-trial-of-mild-to-moderate-atopic-dermatitis-treatment-301713110.html
Jan 4, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next